PDT Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,011
| Closed | -$112K | – | 867 |
|
|
2024
Q3 | $112K | Hold |
30,011
| – | – | 0.01% | 693 |
|
|
2024
Q2 | $168K | Buy |
30,011
+2,953
| +11% | +$16.5K | 0.02% | 624 |
|
|
2024
Q1 | $142K | Buy |
+27,058
| New | +$142K | 0.01% | 597 |
|
|
2023
Q4 | – | Sell |
-19,745
| Closed | -$311K | – | 699 |
|
|
2023
Q3 | $311K | Buy |
+19,745
| New | +$311K | 0.04% | 471 |
|
|
2020
Q1 | – | Sell |
-36,701
| Closed | -$2.21M | – | 890 |
|
|
2019
Q4 | $2.21M | Sell |
36,701
-17,423
| -32% | -$1.05M | 0.14% | 186 |
|
|
2019
Q3 | $3.06M | Sell |
54,124
-976
| -2% | -$55.2K | 0.18% | 155 |
|
|
2019
Q2 | $3.07M | Sell |
55,100
-14
| -0% | -$780 | 0.18% | 145 |
|
|
2019
Q1 | $2.78M | Buy |
55,114
+10,803
| +24% | +$546K | 0.16% | 163 |
|
|
2018
Q4 | $1.79M | Sell |
44,311
-28,289
| -39% | -$1.14M | 0.1% | 213 |
|
|
2018
Q3 | $5.03M | Sell |
72,600
-11,391
| -14% | -$790K | 0.21% | 145 |
|
|
2018
Q2 | $6.36M | Buy |
83,991
+250
| +0.3% | +$18.9K | 0.24% | 137 |
|
|
2018
Q1 | $4.41M | Sell |
83,741
-22,096
| -21% | -$1.16M | 0.15% | 180 |
|
|
2017
Q4 | $5.65M | Buy |
+105,837
| New | +$5.65M | 0.16% | 174 |
|
|
2016
Q1 | – | Sell |
-19,200
| Closed | -$1.7M | – | 606 |
|
|
2015
Q4 | $1.7M | Sell |
19,200
-16,952
| -47% | -$1.5M | 0.23% | 159 |
|
|
2015
Q3 | $2.68M | Buy |
36,152
+9,718
| +37% | +$719K | 0.06% | 354 |
|
|
2015
Q2 | $2.14M | Buy |
26,434
+1,907
| +8% | +$154K | 0.06% | 409 |
|
|
2015
Q1 | $1.03M | Buy |
+24,527
| New | +$1.03M | 0.03% | 790 |
|